How to Place Cosmetic Products on the European Market under Regulation (EC) No 1223/2009
- Maria
- 9 hours ago
- 5 min read
Entering the European Union (EU) cosmetics market requires more than just a great product. Cosmetic manufacturers must meet strict legal requirements before placing products on shelves. Regulation (EC) No 1223/2009 sets out clear rules to ensure product safety, transparency, and consumer protection. Understanding these obligations is essential for successful EU cosmetic registration and market access.

The Role of the EU Responsible Person in Cosmetic Compliance
Every cosmetic product placed on the EU market must have an appointed EU Responsible Person cosmetics. This individual or company acts as the legal representative within the EU and ensures the product complies with Regulation EC 1223/2009. The Responsible Person handles key tasks such as:
Maintaining the Product Information File (PIF cosmetics)
Ensuring the product undergoes a thorough Cosmetic Product Safety Report (CPSR)
Managing CPNP notification before market launch
Overseeing cosmetovigilance and reporting serious undesirable effects
Manufacturers outside the EU must appoint an EU Responsible Person to meet these obligations. This role is critical for legal compliance and smooth market entry.
Preparing the Product Information File and Cosmetic Product Safety Report
The Product Information File is a comprehensive dossier that must be readily available for inspection by EU authorities. It includes:
Product description and intended use
Safety assessment and cosmetic safety assessment documentation
Manufacturing method and compliance with ISO 22716 GMP
Data on ingredients, including an INCI review and allergen information
Labeling and claims substantiation
The Cosmetic Product Safety Report is a key part of the PIF. It evaluates the safety of the product based on toxicological profiles of ingredients, exposure scenarios, and potential risks. A qualified safety assessor must prepare the CPSR to confirm the product is safe for consumers.
Ingredient Review, Allergens, and Labeling Requirements
Ingredient compliance is a cornerstone of cosmetic compliance EU. The EU maintains a list of prohibited and restricted substances, and all ingredients must be declared using the International Nomenclature of Cosmetic Ingredients (INCI). An INCI review ensures the ingredient list is accurate and complete.
Allergens cosmetics EU regulations require specific allergens to be declared on the label if they exceed certain concentrations. This protects consumers with sensitivities and supports transparency.
The cosmetic label review EU covers:
Ingredient list in descending order by weight
Product function and usage instructions
Warnings and precautions
Manufacturer or Responsible Person contact details
Batch number and expiry date
Labels must be clear, truthful, and comply with EU language requirements.
Notification through the Cosmetic Products Notification Portal (CPNP)
Before placing a cosmetic product on the EU market, the Responsible Person must submit a CPNP notification. This electronic notification provides authorities with essential product information, including:
Product category and name
Responsible Person details
Labeling information
CPSR summary and PIF location
The CPNP system enables rapid response in case of safety concerns and supports market surveillance.
Good Manufacturing Practices and Cosmetovigilance
Good Manufacturing Practices (GMP) are essential guidelines that ensure the consistent quality and safety of products, particularly in the pharmaceutical, food, and cosmetics industries. These practices encompass a wide range of operational procedures and standards that manufacturers must adhere to in order to produce products that meet regulatory requirements and consumer expectations. GMP covers various aspects of production, including the facilities, equipment, personnel, and processes involved in manufacturing. One of the fundamental principles of GMP is the emphasis on quality control and assurance throughout the manufacturing process. This means that every stage of production, from raw material sourcing to final product packaging, must be carefully monitored and documented. Regular audits and inspections are conducted to ensure compliance with GMP standards, which helps to identify and rectify any potential issues before they can affect the safety or efficacy of the products. In the realm of cosmetics, GMP plays a crucial role in safeguarding consumer health. The cosmetics industry is subject to specific regulations that dictate the safety and labeling of cosmetic products. By adhering to GMP, manufacturers can minimize the risk of contamination, ensure proper handling of ingredients, and maintain a clean and safe production environment. This not only protects consumers but also enhances the reputation of the brand and fosters consumer trust. Cosmetovigilance, on the other hand, refers to the monitoring of cosmetic products once they are on the market. This practice is vital for identifying and assessing the risks associated with cosmetic products after their release. Cosmetovigilance involves the systematic collection and evaluation of data regarding adverse effects or reactions experienced by consumers. This information is crucial for regulatory authorities, manufacturers, and consumers alike, as it helps to ensure ongoing product safety and efficacy. The integration of GMP and cosmetovigilance creates a comprehensive framework for ensuring the safety of cosmetic products. By implementing robust manufacturing practices, companies can reduce the likelihood of adverse effects occurring in the first place. In addition, an effective cosmetovigilance system allows for the rapid identification and response to any safety concerns that may arise post-market. This dual approach not only protects consumers but also provides manufacturers with valuable insights into product performance and consumer satisfaction. Furthermore, the collaboration between regulatory agencies, manufacturers, and consumers is vital in the realm of cosmetovigilance. Regulatory bodies often provide guidelines and requirements for reporting adverse events, which manufacturers must follow diligently. Consumers, on their part, play an important role by reporting any unexpected reactions they experience, thereby contributing to the safety monitoring process. This collaborative effort enhances the overall safety profile of cosmetic products and helps to inform future manufacturing practices. In conclusion, Good Manufacturing Practices and cosmetovigilance are integral components of the cosmetic industry's commitment to consumer safety. By adhering to GMP, manufacturers ensure that their products are produced under the highest standards of quality and safety. Coupled with an effective cosmetovigilance system, these practices create a robust safety net that protects consumers and promotes confidence in cosmetic products. The ongoing evolution of these practices, driven by technological advancements and consumer feedback, will continue to shape the future of the cosmetics industry, ensuring that safety and quality remain paramount.
Compliance with ISO 22716 GMP ensures cosmetic products are consistently produced and controlled according to quality standards. This reduces risks related to contamination, incorrect labeling, or formulation errors.
Once products are on the market, cosmetovigilance requires ongoing monitoring of product safety. The Responsible Person must collect and evaluate reports of adverse effects and notify authorities of any serious undesirable effects promptly.
How AF Pharma Cosmetics Supports EU Market Access
Navigating the complex requirements of Regulation EC 1223/2009 can be challenging. AF Pharma cosmetics offers expert regulatory consulting to help international brands, startups, and manufacturers achieve EU cosmetics market access efficiently. Our services include:
Acting as your EU Responsible Person cosmetics
Preparing and reviewing Product Information Files and Cosmetic Product Safety Reports
Managing CPNP notification submissions
Conducting thorough cosmetic label review EU and INCI review
Ensuring ingredient and claims compliance
Supporting ongoing cosmetovigilance and regulatory updates
With AF Pharma, you gain a trusted partner to guide your product from development to successful launch in the EU market.




Comments